SUMOylation modulates the transcriptional activity of androgen receptor in a target gene and pathway selective manner

Nucleic Acids Research

Volumn 42, Issue 13, 2014, Pages 8310-8319

  Sutinen, Päivi ^a   Malinen, Marjo ^a   Heikkinen, Sami ^a   Palvimo, Jorma J ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CCAAT ENHANCER BINDING PROTEIN; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; TRANSCRIPTION FACTOR AP 1;

ANDROGEN SYNTHESIS; ARTICLE; BINDING SITE; CELL CYCLE; CELL DEATH; CELL MATURATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE NUMBER; GENE TARGETING; GENETIC SELECTION; HEK293 CELL LINE; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER CELL LINE; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; RECEPTOR OCCUPANCY; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; SUMOYLATION; TRANSCRIPTION REGULATION;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SUMOYLATION; TRANSCRIPTION, GENETIC;

EID: 84905568509     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku543     Document Type: Article

References (41)

1. Siegel, R., Naishadham, D., and Jemal, A. Siegel, R., Naishadham, D., and Jemal, A. (2013) Cancer statistics, 2013. CA Cancer J. Clin., 63, 11-30.
2. Makkonen, H., Kauhanen, M., Paakinaho, V., Jääskeläinen, T., and Palvimo, J.J. Makkonen, H., Kauhanen, M., Paakinaho, V., Jääskeläinen, T., and Palvimo, J.J. (2009) Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers. Nucleic Acids Res., 37, 4135-4148.
3. Sampson, N., Neuwirt, H., Puhr, M., Klocker, H., and Eder, I.E. Sampson, N., Neuwirt, H., Puhr, M., Klocker, H., and Eder, I.E. (2013) In vitro model systems to study androgen receptor signaling in prostate cancer. Endocr. Relat. Cancer, 20, R49-R64.
4. Green, S.M., Mostaghel, E.A., and Nelson, P.S. Green, S.M., Mostaghel, E.A., and Nelson, P.S. (2012) Androgen action and metabolism in prostate cancer. Mol. Cell. Endocrinol., 360, 3-13.
5. Poukka, H., Karvonen, U., Jänne, O., and Palvimo, J. Poukka, H., Karvonen, U., Jänne, O., and Palvimo, J. (2000) Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc. Natl. Acad. Sci. U.S.A., 97, 14145-14150.
6. Flotho, A. and Melchior, F. Flotho, A. and Melchior, F. (2013) Sumoylation: a regulatory protein modification in health and disease. Annu. Rev. Biochem., 82, 357-385.
7. Hay, R.T. Hay, R.T. (2013) Decoding the SUMO signal. Biochem. Soc. Trans., 41, 463-473.
8. Galanty, Y., Belotserkovskaya, R., Coates, J., Polo, S., Miller, K.M., and Jackson, S.P. Galanty, Y., Belotserkovskaya, R., Coates, J., Polo, S., Miller, K.M., and Jackson, S.P. (2009) Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature, 462, 935-939.
9. Heun, P. Heun, P. (2007) SUMOrganization of the nucleus. Curr. Opin. Cell Biol., 19, 350-355.
10. Kaikkonen, S., Jääskeläinen, T., Karvonen, U., Rytinki, M.M., Makkonen, H., Gioeli, D., Paschal, B.M., and Palvimo, J.J. Kaikkonen, S., Jääskeläinen, T., Karvonen, U., Rytinki, M.M., Makkonen, H., Gioeli, D., Paschal, B.M., and Palvimo, J.J. (2009) SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells. Mol. Endocrinol., 23, 292-307.
11. Kotaja, N., Karvonen, U., Jänne, O.A., and Palvimo, J.J. Kotaja, N., Karvonen, U., Jänne, O.A., and Palvimo, J.J. (2002) PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell. Biol., 22, 5222-5234.
12. Poukka, H., Aarnisalo, P., Karvonen, U., Palvimo, J.J., and Jänne, O.A. Poukka, H., Aarnisalo, P., Karvonen, U., Palvimo, J.J., and Jänne, O.A. (1999) Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription. J. Biol. Chem., 274, 19441-19446.
13. Kaikkonen, S., Paakinaho, V., Sutinen, P., Levonen, A., and Palvimo, J.J. Kaikkonen, S., Paakinaho, V., Sutinen, P., Levonen, A., and Palvimo, J.J. (2013) Prostaglandin 15d-PGJ(2) inhibits androgen receptor signaling in prostate cancer cells. Mol. Endocrinol., 27, 212-223.
14. Rytinki, M., Kaikkonen, S., Sutinen, P., Paakinaho, V., Rahkama, V., and Palvimo, J.J. Rytinki, M., Kaikkonen, S., Sutinen, P., Paakinaho, V., Rahkama, V., and Palvimo, J.J. (2012) Dynamic SUMOylation is linked to the activity cycles of androgen receptor in the cell nucleus. Mol. Cell. Biol., 32, 4195-4205.
15. Paakinaho, V., Kaikkonen, S., Makkonen, H., Benes, V., and Palvimo, J.J. Paakinaho, V., Kaikkonen, S., Makkonen, H., Benes, V., and Palvimo, J.J. (2014) SUMOylation regulates the chromatin occupancy and anti-proliferative gene programs of glucocorticoid receptor. Nucleic Acids Res., 42, 1575-1591.
16. Gentleman, R., Carey, V., Bates, D., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., and Gentry, J. et al. Gentleman, R., Carey, V., Bates, D., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., and Gentry, J. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol., 5, R80.
17. Du, P., Kibbe, W.A., and Lin, S.M. Du, P., Kibbe, W.A., and Lin, S.M. (2008) Lumi: a pipeline for processing illumina microarray. Bioinformatics, 24, 1547-1548.
18. Smyth, G.K.3Smyth, G.K. (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol., 3, .
19. Karvonen, U., Kallio, P.J., Jänne, O.A., and Palvimo, J.J. Karvonen, U., Kallio, P.J., Jänne, O.A., and Palvimo, J.J. (1997) Interaction of androgen receptors with androgen response element in intact cells. roles of amino- and carboxyl-terminal regions and the ligand. J. Biol. Chem., 272, 15973-15979.
20. Langmead, B., Trapnell, C., Pop, M., and Salzberg, S.L.R25 Langmead, B., Trapnell, C., Pop, M., and Salzberg, S.L. (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol., 10, .
21. Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y.C., Laslo, P., Cheng, J.X., Murre, C., Singh, H., and Glass, C.K. Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y.C., Laslo, P., Cheng, J.X., Murre, C., Singh, H., and Glass, C.K. (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell, 38, 576-589.
22. Furey, T.S. Furey, T.S. (2012) ChIP-seq and beyond: new and improved methodologies to detect and characterize protein-DNA interactions. Nat. Rev. Genet., 13, 840-852.
23. Quinlan, A.R. and Hall, I.M. Quinlan, A.R. and Hall, I.M. (2010) BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics, 26, 841-842.
24. Ovaska, K., Laakso, M., Haapa-Paananen, S., Louhimo, R., Chen, P., Aittomaki, V., Valo, E., Nunez-Fontarnau, J., Rantanen, V., and Karinen, S. et al. Ovaska, K., Laakso, M., Haapa-Paananen, S., Louhimo, R., Chen, P., Aittomaki, V., Valo, E., Nunez-Fontarnau, J., Rantanen, V., and Karinen, S. (2010) Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme. Genome Med., 2, 65.
25. Edgar, R., Domrachev, M., and Lash, A.E. Edgar, R., Domrachev, M., and Lash, A.E. (2002) Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res., 30, 207-210.
26. Vaidyanathan, G., Cismowski, M.J., Wang, G., Vincent, T.S., Brown, K.D., and Lanier, S.M. Vaidyanathan, G., Cismowski, M.J., Wang, G., Vincent, T.S., Brown, K.D., and Lanier, S.M. (2004) The ras-related protein AGS1/RASD1 suppresses cell growth. Oncogene, 23, 5858-5863.
27. Thomasson, M., Wang, B., Hammarsten, P., Dahlman, A., Persson, J.L., Josefsson, A., Stattin, P., Granfors, T., Egevad, L., and Henriksson, R. et al. Thomasson, M., Wang, B., Hammarsten, P., Dahlman, A., Persson, J.L., Josefsson, A., Stattin, P., Granfors, T., Egevad, L., and Henriksson, R. (2011) LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer. Int. J. Cancer, 128, 2843-2852.
28. Wu, J., Liu, S.L., Zhu, J.L., Norton, P.A., Nojiri, S., Hoek, J.B., and Zern, M.A. Wu, J., Liu, S.L., Zhu, J.L., Norton, P.A., Nojiri, S., Hoek, J.B., and Zern, M.A. (2000) Roles of tissue transglutaminase in ethanol-induced inhibition of hepatocyte proliferation and alpha 1-adrenergic signal transduction. J. Biol. Chem., 275, 22213-22219.
29. Pigazzi, M., Manara, E., Beghin, A., Baron, E., Tregnago, C., and Basso, G. Pigazzi, M., Manara, E., Beghin, A., Baron, E., Tregnago, C., and Basso, G. (2011) ICER evokes Dusp1-p38 pathway enhancing chemotherapy sensitivity in myeloid leukemia. Clin. Cancer Res., 17, 742-752.
30. Song, E.L., Hou, Y.P., Yu, S.P., Chen, S.G., Huang, J.T., Luo, T., Kong, L.P., Xu, J., and Wang, H.Q. Song, E.L., Hou, Y.P., Yu, S.P., Chen, S.G., Huang, J.T., Luo, T., Kong, L.P., Xu, J., and Wang, H.Q. (2011) EFEMP1 expression promotes angiogenesis and accelerates the growth of cervical cancer in vivo. Gynecol. Oncol., 121, 174-180.
31. Sahu, B., Laakso, M., Ovaska, K., Mirtti, T., Lundin, J., Rannikko, A., Sankila, A., Turunen, J.P., Lundin, M., and Konsti, J. et al. Sahu, B., Laakso, M., Ovaska, K., Mirtti, T., Lundin, J., Rannikko, A., Sankila, A., Turunen, J.P., Lundin, M., and Konsti, J. (2011) Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer. EMBO J., 30, 3962-3976.
32. Massie, C.E., Lynch, A., Ramos-Montoya, A., Boren, J., Stark, R., Fazli, L., Warren, A., Scott, H., Madhu, B., and Sharma, N. et al. Massie, C.E., Lynch, A., Ramos-Montoya, A., Boren, J., Stark, R., Fazli, L., Warren, A., Scott, H., Madhu, B., and Sharma, N. (2011) The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J., 30, 2719-2733.
33. Cubenas-Potts, C. and Matunis, M.J. Cubenas-Potts, C. and Matunis, M.J. (2013) SUMO: a multifaceted modifier of chromatin structure and function. Dev. Cell, 24, 1-12.
34. Knutson, T.P., Daniel, A.R., Fan, D., Silverstein, K.A., Covington, K.R., Fuqua, S.A., and Lange, C.A. Knutson, T.P., Daniel, A.R., Fan, D., Silverstein, K.A., Covington, K.R., Fuqua, S.A., and Lange, C.A. (2012) Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression. Breast Cancer Res., 14, .
35. Sharma, N.L., Massie, C.E., Ramos-Montoya, A., Zecchini, V., Scott, H.E., Lamb, A.D., MacArthur, S., Stark, R., Warren, A.Y., and Mills, I.G. et al. Sharma, N.L., Massie, C.E., Ramos-Montoya, A., Zecchini, V., Scott, H.E., Lamb, A.D., MacArthur, S., Stark, R., Warren, A.Y., and Mills, I.G. (2013) The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man. Cancer Cell, 23, 35-47.
36. Robinson, J.L., Macarthur, S., Ross-Innes, C.S., Tilley, W.D., Neal, D.E., Mills, I.G., and Carroll, J.S. Robinson, J.L., Macarthur, S., Ross-Innes, C.S., Tilley, W.D., Neal, D.E., Mills, I.G., and Carroll, J.S. (2011) Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1. EMBO J., 30, 3019-3027.
37. Chng, K.R., Chang, C.W., Tan, S.K., Yang, C., Hong, S.Z., Sng, N.Y., and Cheung, E. Chng, K.R., Chang, C.W., Tan, S.K., Yang, C., Hong, S.Z., Sng, N.Y., and Cheung, E. (2012) A transcriptional repressor co-regulatory network governing androgen response in prostate cancers. EMBO J., 31, 2810-2823.
38. Uhlenhaut, N.H., Barish, G.D., Yu, R.T., Downes, M., Karunasiri, M., Liddle, C., Schwalie, P., Hubner, N., and Evans, R.M. Uhlenhaut, N.H., Barish, G.D., Yu, R.T., Downes, M., Karunasiri, M., Liddle, C., Schwalie, P., Hubner, N., and Evans, R.M. (2013) Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes. Mol. Cell, 49, 158-171.
39. Bertolotto, C., Lesueur, F., Giuliano, S., Strub, T., de Lichy, M., Bille, K., Dessen, P., d'Hayer, B., Mohamdi, H., and Remenieras, A. et al. Bertolotto, C., Lesueur, F., Giuliano, S., Strub, T., de Lichy, M., Bille, K., Dessen, P., d'Hayer, B., Mohamdi, H., and Remenieras, A. (2011) A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature, 480, 94-98.
40. Lee, H.Y., Johnson, K.D., Fujiwara, T., Boyer, M.E., Kim, S.I., and Bresnick, E.H. Lee, H.Y., Johnson, K.D., Fujiwara, T., Boyer, M.E., Kim, S.I., and Bresnick, E.H. (2009) Controlling hematopoiesis through sumoylation- dependent regulation of a GATA factor. Mol. Cell, 36, 984-995.
41. Lee, F.Y., Faivre, E.J., Suzawa, M., Lontok, E., Ebert, D., Cai, F., Belsham, D.D., and Ingraham, H.A. Lee, F.Y., Faivre, E.J., Suzawa, M., Lontok, E., Ebert, D., Cai, F., Belsham, D.D., and Ingraham, H.A. (2011) Eliminating SF-1 (NR5A1) sumoylation in vivo results in ectopic hedgehog signaling and disruption of endocrine development. Dev. Cell, 21, 315-327.